The market is expected to exhibit high growth in
developed economies such as the U.S. and Europe over the forecast period. The
rapid increase in the number of patients suffering from depression is expected
to be one of the main driving forces for the estimated growth, which can be
attributed to elevating stress levels, unhealthy lifestyle, and social
imbalances. In the U.S. and Europe, various regulations pertaining to drug
approval and patents, as well as commercial issues, such as restriction on the
sale of antidepressants without prescription are the major restraints which are
expected to negatively impact market growth. Rise in various medical disorders
due to increase in stress levels and unhealthy lifestyle in Asia Pacific and
the Middle East is expected to lead to market expansion.

The acceptability of various drugs is expected to
increase due to growing public awareness regarding depression and associated
disorders. This is expected to result in increasing drug penetration.

Depression drugs, as the name suggests, are primarily
used for the treatment of depression, and also known as antidepressants. These
drugs are also used in the treatment of a wide range of medical conditions such
as anxiety disorders, neuropathic pain, eating disorders, chronic pain and obsessive
compulsive disorder. The depression drug market includes a wide range of drugs,
and can be segmented on the basis of key product types, which are Tricyclic
antidepressants (TCAs), Serotonin norepinephrine reuptake inhibitors (SNRIs),
Selective serotonin reuptake inhibitors (SSRIs), Monoamine oxidase inhibitors
(MAOIs), and atypical antidepressants.

Some of the key vendors operating in this market
include Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Lundbeck, Forest
Laboratories and others.

This research report analyzes this market depending on
its market segments, major geographies, and current market trends. Geographies
analyzed under this research report include

North
America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis
of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.

The global market for methionine is expected to grow
with growing meat consumption around the world. One of the major factors which
are driving the global market for methionine is increasing meat consumption,
primarily by the increasing population of developing countries such as China,
India, and Brazil etc. Developed economies such as the U.S. and Western Europe
are considered to be mature markets and are expected to grow at a lower rate
compared to developing countries. Methionine is an amino acid that acts
as a building block to form proteins. It is also used for increasing the
quantity of lean meat. Methionine has gradually replaced the market for fish
powder as it is more efficient than fish powder.

China is one of the biggest manufacturers of animal
feed in the world and the country is also one of the biggest consumers of
methionine which is used as a supplement for piglets and ruminants. The
growth of the middle class population in many countries across the world is
also expanding the global market for methionine. However, the volatility in raw
material prices and the rising energy prices, which have a direct impact on the
overall production cost, are acting as the major factors hindering the market
growth.

The concept of bio-based methionine has been there in
the global market for many years now and companies are developing bio-based
methionine for several years. In January, 2012 France based METabolic EXplorer
(METEX) and Roquette joined hands to initialize industrial study on bio-based methionine.
CJ CheilJedang and Arkema are also planning to build bio-based methionine
manufacturing plants in Southeast Asia. The plant is expected to materialize by
the end of 2013 with a capacity to produce 80 kilotons of bio-based methionine
per year.

Some of the companies operating in the global market
for methionine include China National BlueStar, Jinzhou Amino Acid Co., Evonik
Industries, Novus International, Sumitomo Chemical, and Nippon Soda, among
others.

This research report analyzes this market depending on
its market segments, major geographies, and current market trends. Geographies
analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis
of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.

D-amino acid oxidase is a peroxisomal enzyme containing
flavin adenine dinucleotide as a cofactor that is expressed in wide range of
living species such as humans, yeasts etc. In bacteria and plants, they show a
varied form as D-amino acids dehydrogenase, which oxidizes to produce ammonia
and hydrogen peroxide. D-amino acids are compounds made from amine and
carboxylic acid functional groups. Amino acids contain carbon, hydrogen,
oxygen, and nitrogen.

They can be segmented as alpha, beta, gamma, or delta
based on their structure. Amino acids find application in nutritional
supplements, food, and fertilizers, as well as in the commercial sector for the
production of biodegradable plastics, drugs, animal feed supplements, and human
food. They can be used to manufacture a variety of polypeptides, and have very
few substitutes, which results in steady demand. Lysine and glutamic acid
represent the fastest growing amino acids segment; lysine is a critical
additive in animal feed production.

Currently, Asia-Pacific dominates the market followed
by Europe. Countries such India and China, have started developing extensive
industries to produce amino acids for commercial purposes, and the market is
expected to witness high demand over the next few years. China is emerging as a
crucial market for lysine production. Demand for innovative amino acids,
increased processed food consumption, growing demand for animal feed globally,
and the growth of food and drug industries are the major drivers for this
market. Development of organic amino acids for industrial usage and for
polypeptides is a challenge for research personnel.

This research report analyzes this market depending on
its market segments, major geographies, and current market trends. Geographies
analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis
of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

This report is a complete study of current trends in
the market, industry growth drivers, and restraints. It provides market
projections for the coming years. It includes analysis of recent developments
in technology, Porter’s five force model analysis and detailed profiles of top
industry players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with detailed
value chain analysis.

Search This Blog

About Me

The dedicated team of researchers and analysts at Business Research Industry into the Advantage of Knowledge for your company. Data becomes knowledge through the application of Dolcera's optimization process as follows.